Neoneur Feeding System Functionality in the Clinic
NN200
2 other identifiers
interventional
100
1 country
1
Brief Summary
Prospective data collection using the Neoneur Feeding System to demonstrate device functionality, correlation to historic data, and prepare for a more extensive phase II SBIR trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2022
CompletedFirst Submitted
Initial submission to the registry
August 30, 2022
CompletedFirst Posted
Study publicly available on registry
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2024
CompletedSeptember 15, 2023
September 1, 2023
2.1 years
August 30, 2022
September 13, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Maturation
Neoneur 200 measures are corelated to infant maturation in gestational age
6 weeks of data collection
Telehealth functionality
Evaluation of Sending Neoneur 200 data from the bedside to the cloud for used in the hospital and home
6 months
Secondary Outcomes (1)
Respiratory
6 months
Study Arms (1)
Feeding Assessment
EXPERIMENTALFeeding assessment of High-risk premature infants
Interventions
Eligibility Criteria
You may qualify if:
- Preterm infants: requiring tube assisted feeding while in the NICU, gestational age at birth =\<34 week, extubated by term
- Infants with CHD: requiring surgery during the first month of life, gestational age \> 37 weeks
You may not qualify if:
- Premature infants: craniofacial anomalies, infants with grade IV intraventricular hemorrhage, apgar \< 5 at 5 minutes, short gut syndrome, history of NEC
- Infants with CHD: no other congenital anomalies, no history of major neurologic insult , listed for heart transplant, history of ECMO, intubated for \> 4 weeks, requiring additional surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Neoneur LLClead
- National Institutes of Health (NIH)collaborator
- National Institute of Nursing Research (NINR)collaborator
- Children's Hospital of Philadelphiacollaborator
Study Sites (1)
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 08534, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Medoff-Cooper, MSN, PhD
Children's Hospital of Pennsylvania
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2022
First Posted
September 1, 2022
Study Start
July 14, 2022
Primary Completion
August 14, 2024
Study Completion
September 14, 2024
Last Updated
September 15, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
the results will be available and we will seek publication